Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum

This study investigated whether serum components alone can mediate the protective effects of live attenuated simian immunodeficiency virus (SIV) vaccines. Researchers collected immune serum from four cynomolgus macaques chronically infected with attenuated SIVmacC8 that had successfully resisted challenge with wild-type SIVmacJ5. This pooled immune serum was transferred intraperitoneally to two naive macaques, while four control macaques received saline. All six macaques were then challenged with wild-type SIVmacJ5. Despite successful transfer of anti-SIV antibodies to recipient macaques (verified by ELISA), all six animals became infected following viral challenge. Virus loads measured at two weeks post-infection were indistinguishable between serum recipients and controls. The diagnostic PCR confirmed challenge virus rather than vaccine virus was responsible for infections. These results demonstrate that serum antibodies and soluble factors alone cannot transfer the potent protection conferred by live attenuated SIV vaccines, suggesting cellular immune mechanisms play a critical role in vaccine-induced protection. This finding has important implications for developing safer AIDS vaccines that replicate live attenuated vaccine benefits without using infectious agents.

Key findings

• Immune serum from protected macaques successfully transferred anti-SIV antibodies to naive recipients but failed to confer protection against viral challenge
• All six macaques (both serum-treated and control groups) became infected following SIVmacJ5 challenge, with indistinguishable viral loads at two weeks post-infection
• Serum components alone are insufficient to mediate the potent protection obtained with live attenuated SIV vaccines
• Cellular immunity mechanisms, not humoral factors, likely underlie the protection conferred by live attenuated virus infection
• This is the first passive transfer study using serum from donors formally demonstrated to be protected against superinfection